Drug Design Development and Therapy (ERA Journal)

Drug Design Development and Therapy is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Drug Design Development and Therapy issn is: 1177-8881.

The field covered by Drug Design Development and Therapy as part of the evaluation of Australian university research excellence is:

Pharmacology and Pharmaceutical Sciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Pharmacology and Pharmaceutical Sciences field include:

- Acta Physiologica Pharmacologica et Therapeutica Latinoamericana
- Antioxidants and Redox Signaling
- Cancer Biotherapy and Radiopharmaceuticals
- Clinical Psychopharmacology and Neuroscience
- Clinical Therapeutics: the international peer-reviewed journal of drug therapy
- Clinical Toxicology
- International Journal of Clinical Pharmacology and Therapeutics
- Journal of Chinese Pharmaceutical Sciences
- Journal of Research in Pharmaceutical Sciences
- Lekarsky Obzor
- P and T: journal for formulary management
- Pharmaceutical Biology
- Pharmacological Research
- Pharmacopsychiatry
- Therapeutic Advances in Gastroenterology

ERA Research Rankings Submenu

- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List

Latest News and Updates:

- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page